Do Predictors Exist for a Successful Withdrawal of Preoperative Prostaglandin E.sub.1 from Neonates...
Do Predictors Exist for a Successful Withdrawal of Preoperative Prostaglandin E.sub.1 from Neonates with d-Transposition of the Great Arteries and Intact Ventricular Septum?
About this item
Full title
Author / Creator
Publisher
Springer
Journal title
Language
English
Formats
Publication information
Publisher
Springer
Subjects
More information
Scope and Contents
Contents
Prostaglandin E.sub.1 (PGE.sub.1) is given to neonates with d-transposition of the great arteries (d-TGA) to reduce cyanosis by reopening and maintaining the patency of the ductus arteriosus. To avoid side effects, this medication can be stopped for hemodynamically stable patients after balloon atrial septostomy (BAS). A consecutive series of neona...
Alternative Titles
Full title
Do Predictors Exist for a Successful Withdrawal of Preoperative Prostaglandin E.sub.1 from Neonates with d-Transposition of the Great Arteries and Intact Ventricular Septum?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A715517175
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A715517175
Other Identifiers
ISSN
0172-0643
DOI
10.1007/s00246-010-9790-x
